These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21195931)

  • 41. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
    Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
    Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    Ambruso DR; Mahony BS; Githens JH; Rhoades ED
    Am J Pediatr Hematol Oncol; 1982; 4(2):115-23. PubMed ID: 7114394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
    Garzia M; Di Mario A; Ferraro E; Tazza L; Rossi E; Luciani G; Zini G
    Lab Hematol; 2007; 13(1):6-11. PubMed ID: 17353176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Renal anemia and thrombopathy].
    Blumberg A
    Verh Dtsch Ges Inn Med; 1974; 80():625-8. PubMed ID: 4616502
    [No Abstract]   [Full Text] [Related]  

  • 45. Pathophysiology of renal anemia.
    Eckardt KU
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S2-8. PubMed ID: 10746799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation.
    Ferretti G; Bacchetti T; Masciangelo S; Pallotta G
    Clin Biochem; 2008 Apr; 41(6):381-6. PubMed ID: 18194672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics.
    Cotes PM; Pippard MJ; Reid CD; Winearls CG; Oliver DO; Royston JP
    Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous iron therapy in renal failure: friend and foe?
    Afzali B; Goldsmith DJ
    J Nephrol; 2004; 17(4):487-95. PubMed ID: 15372409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anemia in chronic hemodialysis].
    Helbig W; Achenbach H; Löbe J; Gottschild D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):242-57. PubMed ID: 69588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parenteral ascorbic acid in haemodialysis patients.
    Biesalski HK
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):741-6. PubMed ID: 18827578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt/V and patient weight.
    Tovbin D; Markowitz A; Mostoslavsky M; Landver R
    Clin Nephrol; 2000 Apr; 53(4):276-82. PubMed ID: 10809415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.
    Shahrbanoo K; Taziki O
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):933-6. PubMed ID: 18974579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M; Landais P; Canivet E; Yver L; Bataille P; Brillet G; Commenges B; Koné S
    Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
    Böhm V; Tiroke K; Schneider S; Sperschneider H; Stein G; Bitsch R
    Int J Vitam Nutr Res; 1997; 67(4):262-6. PubMed ID: 9285256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma vitamin C levels in ESRD patients and occurrence of hypochromic erythrocytes.
    Seibert E; Richter A; Kuhlmann MK; Wang S; Levin NW; Kotanko P; Handelman GJ
    Hemodial Int; 2017 Apr; 21(2):250-255. PubMed ID: 27619554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fat-soluble vitamins in advanced CKD/ESKD: a review.
    Holden RM; Ki V; Morton AR; Clase C
    Semin Dial; 2012 May; 25(3):334-43. PubMed ID: 22607215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin C in chronic kidney disease and hemodialysis patients.
    Deicher R; Hörl WH
    Kidney Blood Press Res; 2003; 26(2):100-6. PubMed ID: 12771534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemolytic anemia in chronically dialyzed patients induced by free chlorine in tap water (author's transl)].
    Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1979 Jun; 21(6):567-83. PubMed ID: 226761
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal vitamin supplements.
    Nelsen JM; Wagner B
    J Ren Nutr; 2002 Oct; 12(4):E1-E3. PubMed ID: 12382221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.